<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01612182</url>
  </required_header>
  <id_info>
    <org_study_id>ESBL 2012-1</org_study_id>
    <nct_id>NCT01612182</nct_id>
  </id_info>
  <brief_title>The Incidence of Extended-spectrum Î²-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <brief_summary>
    <textblock>
      The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement
      therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy</measure>
    <time_frame>During hospitalization</time_frame>
    <description>The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy</measure>
    <time_frame>during hospitalization</time_frame>
    <description>The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1289</enrollment>
  <condition>End-stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>ESBL(+) Klebsiella pneumonia</arm_group_label>
    <description>All the patient who's the culture result showed ESBL(+) Klebsiella pneumonia in any site during hospitalization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESBL(-) Klebsiella pneumonia</arm_group_label>
    <description>All the patient who's the culture result showed ESBL(-) Klebsiella pneumonia in any site during hospitalization</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>renal replacement therapy</intervention_name>
    <description>renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )</description>
    <arm_group_label>ESBL(+) Klebsiella pneumonia</arm_group_label>
    <arm_group_label>ESBL(-) Klebsiella pneumonia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients had admitted in single center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The age of patient was between 18 yrs and 79 yrs.

          -  The patient who showed Klebsiella pneumonia in 1st culture result of any site during
             hospitalization

        Exclusion Criteria:

          -  The level of serum albumin was below 2.0 or over 5.0

          -  The level of AST or ALT was 2 times of normal level or the level of bilirubin was over
             2.0 mg/dL during 1month.

          -  The level of Body mass index was below 15 or over 30

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Inje University Seoul Paik hospital Instituional Board Review</name>
      <address>
        <city>Seoul</city>
        <state>Je dong 2ga, Jung gu</state>
        <zip>100-032</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2012</study_first_submitted>
  <study_first_submitted_qc>June 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2012</study_first_posted>
  <last_update_submitted>June 4, 2012</last_update_submitted>
  <last_update_submitted_qc>June 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Hoseok Koo</investigator_full_name>
    <investigator_title>Nephrology division, Department of Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>end-stage renal disease</keyword>
  <keyword>renal replacement therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

